Robert B. Ford - 23 Jan 2026 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
CHAIRMAN AND CEO, Director
Signature
/s/ Robert B. Ford by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
23 Jan 2026
Net transactions value
+$2,013,967
Form type
4
Filing time
26 Jan 2026, 08:02:24 UTC
Previous filing
04 Mar 2025
Next filing
26 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ford Robert B CHAIRMAN AND CEO, Director 100 ABBOTT PARK ROAD, ABBOTT PARK /s/ Robert B. Ford by Jessica H. Paik, Attorney-in-Fact 26 Jan 2026 0001612571

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Purchase $2,013,967 +18,800 +9.5% $107.13 216,203 23 Jan 2026 Ford Family Trust F1, F2
holding ABT Common shares without par value 253,305 23 Jan 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.735 to $107.485, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust.